2,3-Dihydro-5-[4-[2-(3,4,5-trimethoxyphenyl)ethyl]phenyl]imidazo[2,1-a]isoquinoline;PAF-AN-1;Imidazo[2,1-a]isoquinoline, 2,3-dihydro-5-[4-[2-(3,4,5-trimethoxyphenyl)ethyl]phenyl]-;PAF AN 1,PAFAN1
PAF-AN-1 is a platelet-activating factor (PAF) receptor antagonist; it inhibits PAF-induced bronchoconstriction and hemoconcentration when administered orally to guinea pigs.